Comments
Loading...

Mangoceuticals Earnings Estimates

MGRXNASDAQ
Logo brought to you by Benzinga Data
$2.23
0.136.19%
At close: -
$2.20
-0.03-1.35%
After Hours: 7:29 PM EDT

Mangoceuticals Earnings Estimates, EPS & Revenue | NASDAQ:MGRX | Benzinga

Mangoceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 15
EPS
$-1.290
Quarterly Revenue
$109.31K
Annual Revenue
(as of Mar 31)
$511.08K

Analyze the earnings history of Mangoceuticals using advanced sorting and filters.

Get Alert
MGRXMangoceuticals-$1.35$163.16K08/13/2025Get Alert
MGRXMangoceuticals-$1.50-$1.29$214.09K$109.31K05/15/2025Get Alert
MGRXMangoceuticals-$1.80-$1.01$244.37K$105.25K03/20/2025Get Alert
MGRXMangoceuticals-$1.65-$0.99$245.16K$133.37K11/14/2024Get Alert
MGRXMangoceuticals-$2.10-$1.35$141.24K$163.16K08/14/2024Get Alert
MGRXMangoceuticals-$3.45-$1.50$100.72K$214.09K05/15/2024Get Alert
MGRXMangoceuticals-$1.80$244.37K04/01/2024Get Alert
MGRXMangoceuticals-$1.50-$1.65$245.16K10/27/2023Get Alert
MGRXMangoceuticals-$0.60-$2.10$0.00$141.24K07/28/2023Get Alert

Mangoceuticals (MGRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %

Mangoceuticals (MGRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Mangoceuticals (NASDAQ:MGRX) reporting earnings?

A

Mangoceuticals (MGRX) is scheduled to report earnings on August 13, 2025. The last reported earnings were for reported on May 15, 2025 for Q1.

Q

What were the latest earnings per share (EPS) for Mangoceuticals (NASDAQ:MGRX)?

A

The Actual EPS was $-1.29, which missed the estimate of $0.00.

Q

What were Mangoceuticals’s (NASDAQ:MGRX) revenues?

A

The Actual Revenue was $109.3K, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch